As of June 2020, 48 percent of the global drug pipeline was for new products, whereas 52 percent of the pipeline focused on indication expansions. This statistic shows the share of indication expansions and new products in the global drug pipeline as of June 2020.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EFPIA. (February 22, 2021). Share of indication expansions and new products in the global drug pipeline as of June 2020 [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 31, 2026, from /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/
EFPIA. "Share of indication expansions and new products in the global drug pipeline as of June 2020." Chart. February 22, 2021. ÌÇÐÄÆƽâ°æ. Accessed July 31, 2026. /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/
EFPIA. (2021). Share of indication expansions and new products in the global drug pipeline as of June 2020. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 31, 2026. /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/
EFPIA. "Share of Indication Expansions and New Products in The Global Drug Pipeline as of June 2020." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 22 Feb 2021, /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/
EFPIA, Share of indication expansions and new products in the global drug pipeline as of June 2020 ÌÇÐÄÆƽâ°æ, /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/ (last visited July 31, 2026)
Share of indication expansions and new products in the global drug pipeline as of June 2020 [Graph], EFPIA, February 22, 2021. [Online]. Available: /statistics/1249175/drug-pipeline-indication-expansion-vs-new-products-worldwide/
